Investigating dopamine receptor binding with PET and SPECT ligands in schizophrenia: clinical and methodological considerations

Author： Klimke A.   Boy C.   Muuml ller-Gauml rtner H.W.   Gaebel W.  

Publisher： Elsevier

ISSN： 0924-977X

Source： European Neuropsychopharmacology, Vol.5, Iss.3, 1995-09, pp. : 318-319

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

123I-β-CIT SPECT demonstrates increased presynaptic dopamine transporter binding sites in basal ganglia in vivo in schizophrenia

By Sjøholm Hans   Bratlid Trond   Sundsfjord Johan  

Psychopharmacology, Vol. 173, Iss. 1-2, 2004-04 ,pp. : 27-31

Springer Publishing Company

Access to resources Recommend Favorite

Synthesis and receptor binding assay of indolin-2-one derivatives as dopamine D4 receptor ligands

By  

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 70, Iss. 8, 2015-01 ,pp. : 511-514

Govi-Verlag

Access to resources Recommend Favorite

Receptor binding studies in schizophrenia

By Sedvall G.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 239-240

Elsevier

Access to resources Recommend Favorite

Receptor Binding Ligands to Image Infection

By  

Current Pharmaceutical Design, Vol. 14, Iss. 31, 2008-11 ,pp. : 3316-3325

Bentham Science Publishers

Access to resources Recommend Favorite

Cannabinoid receptor ligands: clinical and neuropharmacological considerations, relevant to future drug discovery and development

By Pertwee R.G.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 7, 2000-07 ,pp. : 1573-1573

Informa Healthcare

Access to resources Recommend Favorite